Company intelligence / Profile preview

Critical Care

Irvine, California, USA

Ownership: Private
Employees: ~4000
Development stage: Other

Overview

Critical Care is a global leader in advanced monitoring technologies and AI-driven clinical decision support for critically ill patients. Formerly a business unit of Edwards Lifesciences, the company was acquired by Becton, Dickinson and Company (BD) in 2024 to enhance its portfolio in smart connected care. Its flagship products include the HemoSphere monitoring platform and the Acumen IQ sensor, which utilizes predictive analytics to detect potential hypotension before it occurs. The company's solutions are widely used in operating rooms and intensive care units to optimize hemodynamic management and improve patient outcomes.

Therapeutic areas: CardiovascularPulmonologyInfectious Diseases
Modalities: DeviceSoftwareArtificial Intelligence
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Critical Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Critical Care.

Explore the full profile